Langel, Stephanie N. http://orcid.org/0000-0002-0467-7874
Kelly, Francine L.
Brass, David M.
Nagler, Andrew E.
Carmack, Dylan
Tu, Joshua J. http://orcid.org/0000-0001-9391-3375
Travieso, Tatianna
Goswami, Ria
Permar, Sallie R.
Blasi, Maria http://orcid.org/0000-0002-7091-0312
Palmer, Scott M.
Funding for this research was provided by:
Duke | School of Medicine, Duke University (DOM COVID-19 award, Startup funds)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (U01-HL145435-02S1)
Article History
Received: 1 September 2021
Revised: 18 January 2022
Accepted: 27 January 2022
First Online: 15 February 2022
Competing interests
: SRP provides consulting services to Moderna and Merck and Co Vaccines, unrelated to the content of this manuscript. SMP has received consulting fees from Altavant, Theravance, and BMS and received research funding from AZ, BI, and CareDX, unrelated to the content of this manuscript. The authors have declared that no conflict of interest exists.